BioCentury | Jul 28, 2014
Company News

Endo, Medigene sales and marketing update

...15 European countries. Paladin gained exclusive, Canadian rights to the product through its acquisition of Triton Pharma Inc....
BioCentury | Jan 20, 2014
Company News

Paladin, Triton Pharma deal

...to close this half (see BioCentury, Nov. 11, 2013). Paladin Labs Inc. (TSX:PLB), Montreal, Quebec Triton Pharma Inc....
BioCentury | Sep 16, 2013
Clinical News

Veregen sinecatechins regulatory update

...May 23, 2011). Epitome Pharmaceuticals Ltd. , Halifax, Nova Scotia Medigene AG (Xetra:MDG), Martinsried, Germany Triton Pharma Inc....
BioCentury | Apr 25, 2011
Company News

Epitome, Medigene, Mitsui, Triton Pharma Inc. deal

...Halifax, Nova Scotia MediGene AG (Xetra:MDG), Martinsried, Germany Mitsui & Co. Ltd. (Tokyo:8031), Tokyo, Japan Triton Pharma Inc....
Items per page:
1 - 4 of 4
BioCentury | Jul 28, 2014
Company News

Endo, Medigene sales and marketing update

...15 European countries. Paladin gained exclusive, Canadian rights to the product through its acquisition of Triton Pharma Inc....
BioCentury | Jan 20, 2014
Company News

Paladin, Triton Pharma deal

...to close this half (see BioCentury, Nov. 11, 2013). Paladin Labs Inc. (TSX:PLB), Montreal, Quebec Triton Pharma Inc....
BioCentury | Sep 16, 2013
Clinical News

Veregen sinecatechins regulatory update

...May 23, 2011). Epitome Pharmaceuticals Ltd. , Halifax, Nova Scotia Medigene AG (Xetra:MDG), Martinsried, Germany Triton Pharma Inc....
BioCentury | Apr 25, 2011
Company News

Epitome, Medigene, Mitsui, Triton Pharma Inc. deal

...Halifax, Nova Scotia MediGene AG (Xetra:MDG), Martinsried, Germany Mitsui & Co. Ltd. (Tokyo:8031), Tokyo, Japan Triton Pharma Inc....
Items per page:
1 - 4 of 4